Nycomed GmbH
http://www.nycomed.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nycomed GmbH
JPM Day 1: Abbott Riding In Tandem With Libre 2 Plus & t:slim X2 News
The two diabetes players announced a new integration between their products.
“We’re A Pain-Management Company.” Nevro Adds SI Joint Surgery To SCS Business
Nevro is known for its spinal cord stimulation technology but wants to help a wide range of patients with chronic pain, so it is buying Vyrsa, which offers a complete system for sacroiliac joint fusion. In and interview with Medtech Insight, Nevro CEO Kevin Thornal explained how Vyrsa supports Nevro's strategy in this growing market.
No, I Am Spartacus – Embecta Joins The Quell Against GLP-1 Hype
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.
Senseonics See Few Barriers To Adoption For Their Implantable CGM
GLP-1 inhibitors and an ever-shrinking company ecosystem are not issues for the company, according to its CEO.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- OTC, Consumer
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Bradley Pharmaceuticals, Guangdong Techpool Bio-Pharma Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice